Benefits of Glucagon-Like Peptide 1 Receptor Agonists in Kidney Transplant Recipients

被引：0
|
作者：
Garcia, Valencia Oscar Alejandro [1 ]
Sahi, Sukhdeep Singh [1 ]
Na, Jie [1 ]
Smith, Byron H. [1 ]
Budhiraja, Pooja [2 ]
Diwan, Tayyab S. [1 ]
Issa, Naim S. [1 ]
Denic, Aleksandar [1 ]
Abdelrheem, Ahmed [1 ]
Wadei, Hani [3 ]
Kudva, Yogish C. [1 ]
Kukla, Aleksandra [1 ]
机构：
[1] Mayo Clin Minnesota, Rochester, MN USA
[2] Mayo Clin Arizona, Scottsdale, AZ USA
[3] Mayo Clin Florida, Jacksonville, FL USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2024年 / 35卷 / 10期
关键词：
D O I：
10.1681/ASN.2024dtfe7jaj
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
TH-PO743
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Use of glucagon-like peptide type 1 receptor agonists in kidney transplant recipients
    Vigara, Luis Alberto
    Villanego, Florentino
    Orellana, Cristhian
    Eady, Myriam
    Sanchez, Maria Gabriela
    Alonso, Marta
    Garcia, Maria Belen
    Amaro, Jose Manuel
    Garcia, Teresa
    Mazuecos, Auxiliadora
    NEFROLOGIA, 2024, 44 (06): : 885 - 893
  • [2] Glucagon-like peptide 1 receptor agonists and renal outcomes in kidney transplant recipients with diabetes mellitus
    Cohen, Talia Diker
    Rudman, Yaron
    Turjeman, Adi
    Akirov, Amit
    Steinmetz, Tali
    Calvarysky, Bronya
    Dotan, Idit
    DIABETES & METABOLISM, 2025, 51 (03)
  • [3] Weight to go!-Glucagon-like peptide 1 receptor agonists in liver transplant recipients
    Shenoy, Abhishek
    Bloom, Patricia P.
    LIVER TRANSPLANTATION, 2024, 30 (02) : 124 - 126
  • [4] Possible Advantage of Glucagon-Like Peptide 1 Receptor Agonists for Kidney Transplant Recipients With Type 2 Diabetes
    Sato, Tetsuhiko
    Azuma, Yoshinori
    Ozone, Chikafumi
    Okazaki, Mikako
    Takeda, Asami
    Okada, Manabu
    Futamura, Kenta
    Hiramitsu, Takahisa
    Goto, Norihiko
    Narumi, Shunji
    Watarai, Yoshihiko
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (10): : 2597 - 2603
  • [5] Evaluating the Tolerability of Glucagon-Like Peptide-1 Receptor Agonists in Lung Transplant Recipients
    Walshe, C.
    Anderson, M.
    Diamond, J.
    Witek, S.
    Claridge, T.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S643 - S643
  • [6] Evaluating the use of glucagon-like peptide-1 receptor agonists in a matched cohort of kidney and liver transplant recipients
    Baik, Isabel
    Jantz, Arin
    Poparad-Stezar, Adina
    Venkat, Deepak
    Khoury, Nadeen
    Samaniego-Picota, Milagros
    Gonzalez, Humberto C.
    Fitzmaurice, Mary Grace
    JOURNAL OF PHARMACY PRACTICE AND RESEARCH, 2024,
  • [7] Renal Benefits of Glucagon-Like Peptide-1 Receptor Agonists After Kidney Transplantation
    Sahi, S.
    Lemke, A.
    Duffy, D.
    Smith, B.
    Budhiraja, P.
    Diwan, T. S.
    Stegall, M. D.
    Denic, A.
    Wadei, H.
    Park, W.
    Abdelrheem, A. A.
    Shah, P.
    Kudva, Y. C.
    Kukla, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S563 - S564
  • [8] Association of glucagon-like peptide-1 receptor agonists with cardiovascular and kidney outcomes in type 2 diabetic kidney transplant recipients
    Lin, Li-Chun
    Chen, Jui-Yi
    Huang, Thomas Tao-Min
    Wu, Vin-Cent
    CARDIOVASCULAR DIABETOLOGY, 2025, 24 (01)
  • [9] Glucagon-like peptide-1 receptor agonists and kidney outcomes
    MacIsaac, Richard J.
    Trevella, Philippa
    Ekinci, Elif I.
    JOURNAL OF DIABETES, 2024, 16 (10)
  • [10] IMPACT OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS ON METABOLIC HEALTH IN LIVER TRANSPLANT RECIPIENTS
    Spengler, Joseph
    Nguyen, Madison
    Rezzaq, Rehan
    Roche, Geneva
    Patel, Vaishali
    Siddiqui, Mohammad
    Patidar, Kavish
    HEPATOLOGY, 2024, 80 : S436 - S437
12345